U.S. Markets open in 7 hrs 24 mins

Why Alzheimer's Treatment Hopes Endure Despite High-Profile Drug Failures

ALLISON GATLIN
Why Alzheimer's Treatment Hopes Endure Despite High-Profile Drug Failures

Alzheimer's treatment continues to confound biotech companies in the wake of Biogen and Eisai's decision to terminate two late-stage tests. But scientists say there's hope in new theories.